Phytoestrogen is a group of compounds that can replace the estrogen function in the body. One of its roles was as anti-neuroinflammatory by inhibiting the microglia M1 polarity activation. Marsilea crenata Presl. is a plant that suspected to contain phytoestrogens. The aim of this research was to determine the metabolite profile of 96% ethanol extract of M. crenata using UPLC-QToF-MS/MS, and prediction the anti-neuroinflammatory activity of compounds with molecular docking. The 100 ppm of 96% ethanol extract in DCM and methanol were injected 5 µl each into the UPLC-QToF-MS/MS, and then analyzed by Masslynx 4.1 software to determine the compounds. The result of metabolite profiling shows a total 59 compounds in both DCM and methanol. Molecular docking was done with Autodock 4.2.6. After being analyzed, there are 3 compounds that are predicted to have activities similar to 17β-estradiol, they are prochlorperazine, 12-Aminododecanoic acid, and 1-methyl-2-[(4-methylpiperazin-1-yl)methyl]benzimidaol-5-amine hydrochloride. The results showed that the three compounds were predicted to be phytoestrogen compounds from M. crenata leaves, which have potential as anti-neuroinflammatory.
INTRODUCTION
Marsilea. crenata Presl. is an aquatic plant that widely used as an ingredient for traditional food in Surabaya, Indonesia [1, 2] . Some of the research that had been done showed that 96% ethanol extract, n-hexane extract, and ethyl acetate extract of M. crenata leaves can inhibit osteoporosis in female mouse (mus musculus) with mechanism of bone formation improvement [3] [4] [5] [6] . Other studies were also showed that n-hexane extract of M. crenata leaves can increase the alkaline phosphatase production in MC3T3-E1 preosteoblast cell differentiation process, which indirectly also play a role in bone formation improvement [3, 7] .
This activity appears to be suspected because of the phytoestrogens content in M. crenata. Phytoestrogens are a group of compounds contained in plants which have estrogen-like structures or can replace the function of estrogen, either in association with estrogen receptors (ER-dependent) or not (ER-independent) [8] [9] [10] . The high phytoestrogen content in M. crenata raises allegations of its activity as a neuroprotective agent with antineuroinflammatory mechanism. This mechanism can occur due to inhibition of microglia cells M1 polarity activation, where phytoestrogens bind to ER-β in microglia cells and prevent their activity to induce neuron apoptosis [11, 12] .
Although it has great potential as a medicinal plants, the phytochemical properties of M. crenata has not been completely confirmed yet. This research was done to identify the metabolite profile of 96% ethanol extract of M. crenata using UPLC-QToF-MS/MS, which is a powerful technique used for metabolite profiling which has improved in performance of chromatographic resolution, speed and sensitivity analysis, saves time, also reduces solvent consumption [13] .
The in silico approach was used to develop new drugs from M. crenata leaves as anti-neuroinflammatory, as a preliminary test with the principle of tethering compounds from metabolite profiling analysis to a certain macromolecules such as ER-β, and determine the physicochemical properties of compounds against it [14] . Through the in silico approach, researchers can make the initial hypothesis and make simple predictions related to the potential activity of compounds, by correlating the structure and physicochemical properties using software analysis [15] . 
METHODS

Material
Extraction
Dry powder of M. crenata leaves were extracted with 96% ethanol using ultrasonic assisted extraction methods (Sonica 5300EP S3). This process was repeated, collecting all the supernatants, which were finally evaporated in a rotary evaporator (Heidolph) to get 96% ethanol extract. 
Metabolite Profiling by UPLC-QToF-MS/MS
A simple, rapid, reliable and precise reversed phase UPLC-QToF-MS/MS method has been developed and validated according to the regulator guidelines. The 96% ethanol extract preparation was done using solid phase extraction, 100 ppm of ethyl acetate extract in DCM and methanol then injected 5 µl each into the an ACQUITY UPLC® H-Class System (Waters, USA) coupled to an MS detector Xevo G2-S QToF (Waters, USA). Sample were separated on an ACQUITY BEH C18 (1.7 µm 2.1×50 mm) with acetonitril + 0.05 % formic acid and water + 0.05 % formic acid as mobile phase, with flowrate 0.2 ml/min. The results of UPLC-MS analysis was processed using the Masslynx 4.1 software, to obtain the data of peak and m/z spectra of each detected peak. The compound content can then be predicted using the chemspider website.
Molecular Docking Simulation
Receptor structure of ER-β used in this research was obtained from Protein Data Bank (http://www.rcsb.org) with code 3OLS [16] . Initial preparation was done to separate internal ligand (17βestradiol) from the protein using Biovia Discovery Studio Visualizer 2016. The secondary metabolite of M. crenata was prepared with SwissADME Web Tool [17] to predict its physicochemicals properties.
The compounds that were predicted to penetrate the brain by using BOILED-Egg method [18] will be used for the next step as test compounds. Internal ligand and test compounds was prepared with Avogrado 1.90.0 for energy optimization by using MMF94s method. Molecular docking was done using Pyrx 0.8 [19] with Autodock Vina [20] for molecular docking simulation. The receptor-ligand complexes from docking simulation were visualized using Biovia Discovery Studio Visualizer 2016.
RESULTS AND DISCUSSION
Metabolite Profiling by UPLC-QToF-MS/MS
A total of 440 g dry powder of M. crenata leaves were extracted with 96% ethanol to produce 7 g extract. The 96% ethanol extract of M. crenata were analysed by UPLC-QToF-MS/MS to better interpret the diversity of available phytochemicals. Table 1 and Table 2  summarise all the compounds characterized in 96% ethanol extract of M. crenata leaves, including retention times, % area, measured m/z, molecular formula, putative compounds, and its activity based on references. In total there were 42 peak of compounds identified in the methanol solvent, and 33 peak in the DCM solvent. The use of two types of solvent aimed to elute the 96% ethanol extract optimally.
From all the peaks, only 59 peaks can be identified, while the rest are unknown compounds. Unknown compounds may be identified as impure compounds which are still detected by the instrument, or they may be a new compounds, which is undetectable in chemspider database, especially unknown compounds with high concentrations.
Molecular Docking Simulation
The 59 compounds from the metabolite profiling analysis were screened by using SwissADME Web Tool [17] to predict the ability of compounds to penetrate BBB. The method used was the Boiled-EGG method [18] , where the compounds that have topology polar surface area (TPSA) value 0-79 Å 2 [21] and a logP value 0.4-6.0 possess the ability to penetrate the blood brain barrier (BBB). From the results of the analysis, there are 19 compounds that are predicted to be able to penetrate the BBB.
The compounds then analyzed with molecular docking using the PyRx 0.8 program and AutoDock Vina [20] as a docking simulator. From the redocking test, the RMSD value was < 2 Å, so that the docking protocol can be used to docking the 19 compounds ( Figure 2 ). From the results of analysis with Discovery Studio Visualizer 2016, it was found that there were 3 compounds predicted as ER-β agonists such as DCM10, MTL7, and MTL17 (Table 3) , 6 compounds predicted as ER-β antagonist such as DCM4, DCM11, DCM14, DCM24, and MTL6 (Table 4) , and 10 compounds do not have activity in ER-β. To be able to act as an ERβ agonist, the compound must interact with His475 amino acid residues and interact either with Glu305 or Arg346. The absence of interaction between the compound and His475 residue will cause the compound to act as an ER-β antagonist. From the Boiled-Egg diagram in Figure 3 , it can be observed that the three compounds which act as ER-β agonist and 17β-estradiol as positif control are in the yellow region, which indicates that these compounds can penetrate the BBB and can work on ER-β. In the diagram, all compounds except DCM10 (12aminododecanoic acid) has a blue colour indicating that it can bind to the P-gp substrate in the brain, which causes the compound to have a short duration of action and easily excreted from the body [17] . While the DCM10 did not show any bond with the P-gp substrate, so it could work with longer duration in the brain [40] .
ER-β is present in several types of cells in the brain, one of them is microglia cells. Microglia cells are responsible for the neuroinflamation process which is one of the main neurodegenerative causes [11] . In neuroinflamation, an increase in the immune system response characterized by an increase in the number of microglia cells activated in M1 polarity pathway due to estrogen deficiency, causes an increase in inflammatory cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and nitric oxide (NO) in the brain [41] . This event will reduce synaptic function and neuronal plasticity, and induce neuronal cell apoptosis [11, 41] . Even so, further research is still needed to ascertain the activity of compounds in 96% ethanol extract of M. crenata leaves as antineuroinflammatory.
CONCLUSIONS
From UPLC-QToF-MS/MS analysis, There were 75 compounds contained in 96% ethanol extract of M. crenata leaves, either detected compounds (59 compounds), or unknown compounds. The molecular docking simulation shows there are 3 compounds that are predicted to have activities similar to 17β-estradiol as anti-neuroinflammatory, they are prochlorperazine, 12-Aminododecanoic acid, and 1-methyl-2-[(4-methylpiperazin-1-yl)methyl]benzimidaol-5-amine hydrochloride. [9] Yang, T-S., Wang, S-Y., Yang, Y-C., Su, C-H., Lee, F-K., Chen, S-C., Tseng, C-Y., Jou, H-J., Huang, J-P., 
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